Cargando…
Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma
A 69-year-old male was diagnosed in February 2004 with stage IV extranodal marginal zone B cell lymphoma involving the mediastinal nodes, lung parenchyma and bone marrow with high LDH. Shortness of breath developed following the 5th course of Rituximab-CHOP chemotherapy (cyclophosphamide, Vincristin...
Autores principales: | Kim, Kwang Min, Kim, Ho-Cheol, Jeon, Kyung-Nyeo, Kim, Hoon-Gu, Kang, Jung Hun, Hahm, Jong Ryeal, Lee, Gyeong-Won |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615269/ https://www.ncbi.nlm.nih.gov/pubmed/18306483 http://dx.doi.org/10.3349/ymj.2008.49.1.155 |
Ejemplares similares
-
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
por: Alderuccio, Juan Pablo, et al.
Publicado: (2022) -
Primary extranodal marginal zone lymphoma – Epididymis
por: Rajaian, Shanmugasundaram, et al.
Publicado: (2011) -
Extranodal marginal zone lymphoma: an unusual cause of gastric subepithelial tumor
por: Park, Eun Young, et al.
Publicado: (2020) -
Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
por: Jang, Geundoo, et al.
Publicado: (2011) -
Extranodal Marginal Zone Lymphoma Occurring along the Trachea and Central Airway
por: Kang, Ji Young, et al.
Publicado: (2008)